BAXTER INTERNATIONAL INC — Investor Relations & Filings
Filings indexed
2,456
across all filing types
Latest filing
2018-09-19
Director's Dealing
Country
US
United States of America
Listing
US
BAX
Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| PRIMARY DOCUMENT | 2018-09-19 | English | |
| PRIMARY DOCUMENT | 2018-09-19 | English | |
| PRIMARY DOCUMENT | 2018-09-05 | English | |
| PRIMARY DOCUMENT | 2018-09-05 | English | |
| PRIMARY DOCUMENT | 2018-09-05 | English | |
| S-3ASR | 2018-08-23 | English |
Browse filings by year
33 years- 2026 34 filings
- 2025 80 filings
- 2024 86 filings
- 2023 90 filings
- 2022 82 filings
- 2021 91 filings
- 2020 85 filings
- 2019 99 filings
- 2018 89 filings
- 2017 114 filings
- 2016 170 filings
- 2015 139 filings
- 2014 85 filings
- 2013 109 filings
- 2012 76 filings
- 2011 70 filings
- 2010 91 filings
- 2009 83 filings
- 2008 90 filings
- 2007 72 filings
- 2006 77 filings
- 2005 73 filings
- 2004 56 filings
- 2003 175 filings
- 2002 84 filings
- 2001 26 filings
- 2000 22 filings
- 1999 21 filings
- 1998 27 filings
- 1997 18 filings
- 1996 18 filings
- 1995 14 filings
- 1994 10 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2018
15 filings
| |||||
| 8206079 | PRIMARY DOCUMENT | 2018-09-19 | English | ||
| 8206080 | PRIMARY DOCUMENT | 2018-09-19 | English | ||
| 8206081 | PRIMARY DOCUMENT | 2018-09-05 | English | ||
| 8206084 | PRIMARY DOCUMENT | 2018-09-05 | English | ||
| 8206085 | PRIMARY DOCUMENT | 2018-09-05 | English | ||
| 8206089 | S-3ASR | 2018-08-23 | English | ||
| 8206125 | FORM 8-K | 2018-08-23 | English | ||
| 8206126 | PRIMARY DOCUMENT | 2018-08-13 | English | ||
| 8206130 | PRIMARY DOCUMENT | 2018-08-13 | English | ||
| 8206135 | PRIMARY DOCUMENT | 2018-08-10 | English | ||
| 8206187 | 10-Q | 2018-08-06 | English | ||
| 8206189 | 8-K | 2018-07-26 | English | ||
| 8206191 | 8-K | 2018-07-17 | English | ||
| 8206193 | PRIMARY DOCUMENT | 2018-07-12 | English | ||
| 8206196 | 11-K | 2018-06-29 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
BAXTER INTERNATIONAL INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30537/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30537 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30537 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30537 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30537}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BAXTER INTERNATIONAL INC (id: 30537)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.